Podcast 16: CDMOs Step Up to the COVID Challenge but Must Prepare for Uncertain Future

In this podcast we feature an article that looks at the near-term and long-term impact of the COVID-19 pandemic as biopharma companies re-access drug-development projects.  For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

  • The CDMO industry in the wake of COVID-19
  • Near-term outlook
  • Medium-term could be challenging
  • Longer-term implications
Leave a Reply

Your email address will not be published. Required fields are marked *